AB Artea bankas, together with its subsidiaries, provides commercial banking products and services to private and corporate customers in Lithuania. It operates through Corporate; Private; and Investment segments. The company offers various deposits; debit and credit cards; consumer, secured, mortgage, multi-apartment house renovation, and short- and long-term loans, as well as credits for farmers and credits with structural instruments; and savings and investment products. It also provides payment, cash operations, trade finance, car and operating leases, factoring, e-banking, foreign exchange, currency risk management, money transfer, documentary settlement, currency exchange, liquidity portfolio, life insurance, real estate management, fund and investment management, and other services. AB Artea bankas was formerly known as AB Siauliu Bankas and changed its name to AB Artea bankas in May 2025. The company was incorporated in 1992 and is headquartered in iauliai, Lithuania.…
What Is Novartis (SWX:NOVN) Gaining From Its PMR Approval And ADC Deal?
AB Artea bankas (VLN: ROE1L) is listed on Nasdaq Vilnius, where its shares trade in EUR. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 1,336 employees.
The shares were at 0.8110 EUR on 20 November 2026, up 3.9% over 52 weeks. Its 52-week range is 0.8100 EUR to 0.9690 EUR, and it trades at the bottom of that range.
At a market capitalisation of 529.10M EUR, it trades at 13.5 times trailing earnings and 6.2 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 31% for ROE1L. It pays a dividend yielding 5.72% (it pays out 78% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
AB Artea bankas reports return on equity of 10.1%, an operating margin of 27.5% and revenue down 16.3% year over year.
Its debt exceeds its cash by 577.47M EUR, a debt-to-equity ratio of 1.72. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 1.045 EUR is 28.9% above the current price.